Fluvastatin XL therapy may prevent adverse cardiac outcomes in patients undergoing major vascular surgery: Results from the DECREASE III trial

Revision as of 20:13, 16 February 2009 by Jacki Buros (talk | contribs) (Fluvastatin XL therapy may prevent adverse cardiac outcomes in patients undergoing major vascular surgery: Results from the DECREASE III trial moved to [[News:Fluvastatin XL therapy may prevent adverse cardiac outcomes in patients undergoing major vas)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Redirect page
Jump to navigation Jump to search

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Fluvastatin_XL_therapy_may_prevent_adverse_cardiac_outcomes_in_patients_undergoing_major_vascular_surgery:_Results_from_the_DECREASE_III_trial&oldid=532757"